- Home
- Publications
- Publication Search
- Publication Details
Title
Amyloid β oligomers (AβOs) in Alzheimer’s disease
Authors
Keywords
Amyloid-β oligomer, Protein aggregation, Biomarkers, Cerebrospinal fluid, Alzheimer’s disease, Neurodegeneration
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 125, Issue 2, Pages 177-191
Publisher
Springer Nature
Online
2017-12-01
DOI
10.1007/s00702-017-1820-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Load of Amyloid-β Oligomers is Decreased in the Cerebrospinal Fluid of Alzheimer's Disease Patients
- (2018) Giulia M. Sancesario et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-β Oligomers in Cerebrospinal Fluid are Associated with Cognitive Decline in Patients with Alzheimer's Disease
- (2018) Alexander Navarrete Santos et al. JOURNAL OF ALZHEIMERS DISEASE
- The Amyloid-β Oligomer Count in Cerebrospinal Fluid is a Biomarker for Alzheimer's Disease
- (2018) Lei Wang-Dietrich et al. JOURNAL OF ALZHEIMERS DISEASE
- Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice
- (2017) Jordano Brito-Moreira et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Modified Immunotherapies Against Alzheimer's Disease: Toward Safer and Effective Amyloid-β Clearance
- (2017) Yan-Jiang Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Interference from Heterophilic Antibodies in Amyloid-β Oligomer ELISAs
- (2017) Dag Sehlin et al. JOURNAL OF ALZHEIMERS DISEASE
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment
- (2016) Laia Montoliu-Gaya et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex
- (2016) Flavio H. Beraldo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
- (2016) Ting Yang et al. JOURNAL OF NEUROSCIENCE
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Theo Vos et al. LANCET
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Molecular Mechanisms of Amyloid Oligomers Toxicity
- (2016) Rakez Kayed et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
- (2015) Kirsten L. Viola et al. ACTA NEUROPATHOLOGICA
- Toxic species in amyloid disorders: Oligomers or mature fibrils
- (2015) Vibha Taneja et al. Annals of Indian Academy of Neurology
- Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer’s disease
- (2015) Laura T. Haas et al. BRAIN
- Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer’s disease
- (2015) Alaina Baker-Nigh et al. BRAIN
- Aβ42 oligomers selectively disrupt neuronal calcium release
- (2015) Cristian Lazzari et al. NEUROBIOLOGY OF AGING
- Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
- (2015) Elvira Valera et al. Neurotherapeutics
- How does brain insulin resistance develop in Alzheimer's disease?
- (2014) Fernanda G. De Felice et al. Alzheimers & Dementia
- Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
- (2014) Christiane Reitz et al. BIOCHEMICAL PHARMACOLOGY
- Plasma Amyloid-β Oligomers and Soluble Tumor Necrosis Factor Receptors as Potential Biomarkers of AD
- (2014) Jinbiao Zhang et al. Current Alzheimer Research
- Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits
- (2014) Eric C. Miller et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Type 3 diabetes is sporadic Alzheimer׳s disease: Mini-review
- (2014) Suzanne M. de la Monte EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A Sensitive A Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid
- (2014) M. J. Savage et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's disease: The forgetting gene
- (2014) Laura Spinney NATURE
- Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes
- (2014) Soyon Hong et al. NEURON
- Immunotherapy for Alzheimer’s disease: past, present and future
- (2014) Brian Spencer et al. Frontiers in Aging Neuroscience
- Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease
- (2014) Gary P Morris et al. Acta Neuropathologica Communications
- Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples
- (2013) Andrew D. Watt et al. ACTA NEUROPATHOLOGICA
- Pathogenesis of Abeta Oligomers in Synaptic Failure
- (2013) Senthilkumar Sivanesan et al. Current Alzheimer Research
- Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
- (2013) Yun Li et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers
- (2013) Nadine D. Younan et al. FASEB JOURNAL
- Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice
- (2013) Suhail Rasool et al. JOURNAL OF NEUROCHEMISTRY
- Changes in Brain Function Occur Years before the Onset of Cognitive Impairment
- (2013) L. L. Beason-Held et al. JOURNAL OF NEUROSCIENCE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Immunotherapy for Alzheimer’s disease: hoops and hurdles
- (2013) Cynthia A Lemere Molecular Neurodegeneration
- Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
- (2013) Ji Won Um et al. NEURON
- Environmental Novelty Activates β2-Adrenergic Signaling to Prevent the Impairment of Hippocampal LTP by Aβ Oligomers
- (2013) Shaomin Li et al. NEURON
- Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples
- (2013) Takashi Kasai et al. NEUROSCIENCE LETTERS
- Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
- (2013) Mikko Hölttä et al. PLoS One
- A Luminex Assay Detects Amyloid β Oligomers in Alzheimer’s Disease Cerebrospinal Fluid
- (2013) Adrianna Z. Herskovits et al. PLoS One
- Human LilrB2 Is a -Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer's Model
- (2013) T. Kim et al. SCIENCE
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue
- (2012) Kim A. Bruggink et al. ANALYTICAL BIOCHEMISTRY
- Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls
- (2012) Thomas J. Esparza et al. ANNALS OF NEUROLOGY
- Conformational Differences between Two Amyloid β Oligomers of Similar Size and Dissimilar Toxicity
- (2012) Ali Reza A. Ladiwala et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- β2-Adrenergic receptor supports prolonged theta tetanus-induced LTP
- (2012) Hai Qian et al. JOURNAL OF NEUROPHYSIOLOGY
- A neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors
- (2012) H. You et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Neurochemical dementia diagnostics in Alzheimer’s disease: where are we now and where are we going?
- (2011) Piotr Lewczuk et al. Expert Review of Proteomics
- Reduced levels of the tyrosine phosphatase STEP block beta amyloid-mediated GluA1/GluA2 receptor internalization
- (2011) Yongfang Zhang et al. JOURNAL OF NEUROCHEMISTRY
- Brain Oligomeric β-Amyloid but Not Total Amyloid Plaque Burden Correlates With Neuronal Loss and Astrocyte Inflammatory Response in Amyloid Precursor Protein/Tau Transgenic Mice
- (2011) Bibiana DaRocha-Souto et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Resolving controversies on the path to Alzheimer's therapeutics
- (2011) Dennis J Selkoe NATURE MEDICINE
- Interacting brain systems modulate memory consolidation
- (2011) Christa K. McIntyre et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease
- (2010) Eric R. Siemers et al. CLINICAL NEUROPHARMACOLOGY
- Bapineuzumab
- (2010) Geoffrey A Kerchner et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
- (2010) Hiroaki Fukumoto et al. FASEB JOURNAL
- Interaction between Human Prion Protein and Amyloid-β (Aβ) Oligomers
- (2010) Shugui Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease
- (2010) Carol Man Gao et al. PLoS One
- A Specific Enzyme-Linked Immunosorbent Assay for Measuring β-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer Disease
- (2009) Weiming Xia et al. ARCHIVES OF NEUROLOGY
- Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease
- (2009) Nigel J. Cairns et al. ARCHIVES OF NEUROLOGY
- Assembly of a β2-adrenergic receptor—GluR1 signalling complex for localized cAMP signalling
- (2009) Mei-ling A Joiner et al. EMBO JOURNAL
- Oligomers of β-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model
- (2009) Renee C. Gaspar et al. EXPERIMENTAL NEUROLOGY
- Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption
- (2009) Wei-Qin Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia
- (2009) Cindy M Sondag et al. Journal of Neuroinflammation
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
- (2009) Juha Laurén et al. NATURE
- Oligomerization Partially Explains the Lowering of Aβ42 in Alzheimer’s Disease Cerebrospinal Fluid
- (2009) Hillevi Englund et al. Neurodegenerative Diseases
- Memory and the NMDA Receptors
- (2009) Fei Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oligomeric amyloid associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
- (2009) R. M. Koffie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Classification of Toxic Amyloid Oligomers
- (2008) Charles G. Glabe JOURNAL OF BIOLOGICAL CHEMISTRY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Peripheral A subspecies as risk biomarkers of Alzheimer's disease
- (2008) N. Schupf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PET imaging of amyloid deposition in patients with mild cognitive impairment
- (2007) Anton Forsberg et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More